Fairbanks, AKNCT07091617Now EnrollingIRB Ready

Miscellaneous Neoplasm, Nos Clinical Trial in Fairbanks, AK

Access cutting-edge miscellaneous neoplasm, nos treatment through this clinical trial at a research site in Fairbanks. Study-provided care at no cost to qualified participants.

Sponsored by Alliance for Clinical Trials in Oncology

Quick Self-Assessment

See if you qualify for this Fairbanks location

Preparing your pre-screening questions…

Expert Care in Fairbanks

Access miscellaneous neoplasm, nos specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related miscellaneous neoplasm, nos treatment provided free

Apply for This Fairbanks Location

Check if you qualify for this miscellaneous neoplasm, nos clinical trial in Fairbanks, AK

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fairbanks

    Convenient for AK residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fairbanks site if eligible
  4. 4Begin participation

About This Miscellaneous Neoplasm, Nos Study in Fairbanks

This phase III trial compares the use of a digital chatbot enabled intervention to standard remote genetic services for increasing uptake of genetic counseling and testing among adolescents and young adult (AYA) cancer patients. Genetic testing for cancer predisposition syndromes has become standard evidence-based practice and can inform enhanced screening and risk reducing measures to reduce cancer morbidity and mortality. Despite this, many AYAs are not receiving recommended genetic counseling and testing. Offering remote telehealth services can address access barriers and chatbots and texting interventions could enhance patient outcomes and reduce provider and staff time. The use of a digital chatbot enabled intervention may be equally as effective as standard remote genetic services in AYA cancer patients undergoing genetic testing.

Sponsor: Alliance for Clinical Trials in Oncology

Who Can Participate

Inclusion Criteria

PATIENTS: Age ≥ 18 years and ≤ 39 years at the time of enrollment
PATIENTS: AYA cancer patients and survivors. This includes patients at any stage of diagnosis (e.g., newly diagnosed, in treatment, in survivorship) and a cancer diagnosis (including pediatric cancers) at any age ≤ 39 years old. Given targeted therapies for BRCA+ and microsatellite instability (MSI)-high/Lynch Syndrome patients and benefit to relatives, patients with metastatic cancer are included. Any history of cancer, regardless of being in treatment or not
PATIENTS: Language: In order to complete the mandatory patient-completed measures and receive genetic education and counseling, participants must be able to speak and read English or Spanish
PATIENTS: No known diagnosis of dementia or cognitive impairment. Persons with impaired decision-making capacity are ineligible as they need to be able to understand genetic test results, its implications for the patient and family, and explain genetic test results to their family members
PATIENTS: No persons with a known psychiatric or documented developmental disorder that affects cognitive or emotional functions to the extent that the capacity for judgment and reason is significantly diminished, such that they cannot participate based on the judgment of the treating physician
PATIENTS: Participants must meet National Comprehensive Cancer Network (NCCN) guidelines for genetic testing assessment provided by Penn Telegenetics by the Eligibility Verification Assessment (EVA) chatbot, or paper forms and genetic counselor's review
NON-PATIENT PARTICIPANT: Non-patient participants eligible for this study include: oncology providers, members of the care team and clinic staff, genetic counselors, and insurers (i.e., people who work in financial services and/or for insurance companies) who participate in oncology care among AYA in community for this study
NON-PATIENT PARTICIPANT: Age ≥ 18 years
NON-PATIENT PARTICIPANT: Non-patient participants must be able to speak and read English or Spanish in order to participate in the key informant interviews

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fairbanks?

Yes, this clinical trial (NCT07091617) has an active research site in Fairbanks, AK that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Miscellaneous Neoplasm, Nos Treatment Options in Fairbanks, AK

If you're searching for miscellaneous neoplasm, nos treatment options in Fairbanks, AK, this clinical trial (NCT07091617) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fairbanks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced miscellaneous neoplasm, nos specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all miscellaneous neoplasm, nos clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Fairbanks, AK

See all heart attack clinical trials recruiting in Fairbanks — not just this study.

Browse Heart Attack Trials in Fairbanks →

Browse More Trials by Condition

Heart Attack TrialsAnkylosing Spondylitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Fairbanks?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fairbanks, AK